Radiotherapy in Practice - Radioisotope Therapy
Peter J Hoskin
OUP Oxford, Feb 8, 2007 - Medical - 189 pages
Radioisotope therapy is an internal form of radiation used to treat cancer; it may be administered orally or intravenously and represents the nearest treatment option to the 'magic bullet', specifically targeting sites of disease whilst sparing surrounding normal tissues. Radioisotope therapy has an important role to play in modern medicine, particularly in the treatment of thyroid disease, neuroendocrine tumours, bone metastasis and non-Hodgkin's lymphoma. It is found in both the diagnostic setting and in therapy, but recently there has been a renaissance in the application of radioisotope unsealed sources in therapeutic indications. It is an active area of research, with the quest for new compounds that will be specific for therapeutic targets. This book is an essential, practical guide to the use of radioisotope therapy, and also includes the background and developmental biology which underpins its use. Individual tumours and diseases are explored, with specific focus given to radioisotope treatment options. The barriers to radioisotope therapy, such as ease of access, acquisition of radioisotopes, radiation protection regulations, and cost are also discussed. ABOUT THE SERIES Radiotherapy remains the major non-surgical treatment modality for the management of malignant disease, with over 50% of patients receiving treatment at some time during the management of their malignant disease. It is based on the application of the principles of applied physics, radiobiology, and tumour biology to clinical practice. Each volume in this series takes the reader through the basic principles of different types of radiotherapy, and then develops these by individual sites. This series of practical handbooks are aimed at physicians both training and practising in radiotherapy, as well as medical physicists, dosimetrists, radiographers and senior nurses.
What people are saying - Write a review
We haven't found any reviews in the usual places.
1 Physics principles in the clinical use of radioisotopes
2 Antibody directed radioisotope therapy
use of sup131I
use of sup131I
5 Neuroendocrine tumours
6 Radioisotope therapy for metastatic bone disease
Other editions - View all
131I radioiodine 131I-tositumomab 90Y-ibritumomab tiuxetan ablation activity administration antigen Biology blood bone marrow bone metastases Cancer Research carcinoid carcinoid tumours chemotherapy Clinical Endocrinology Clinical Oncology contamination differentiated thyroid disease dose rate dosimetry EBRT effect efficacy emission emitters Endocrinology and Metabolism European Journal euthyroid exposure external beam external beam radiotherapy follicular follow-up goitre haematological half-life hormone hyperthyroidism ibritumomab imaging increase infusion iodine isotope Journal of Cancer Journal of Clinical Journal of Nuclear liver malignant median metastatic molecules monitoring monoclonal antibody neuroendocrine tumours non-Hodgkin’s lymphoma normal tissues Nuclear Medicine patients pre-dose prostate cancer radiation dose radioactive radioimmunotherapy radioiodine radioiodine therapy radioisotope radioisotope therapy radiolabelled radionuclide radionuclide therapy radiopharmaceutical receptor renal reported response rate rhenium rituximab samarium SMS analogues staff strontium surgery targeted therapeutic thyroid cancer thyroid carcinoma tositumomab toxicity tracer scan treated treatment tumour cells uptake xenografts